These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38531102)

  • 61. Safety, Immunogenicity, and Protective Efficacy of Intradermal Immunization with Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites in Volunteers Under Chloroquine Prophylaxis: A Randomized Controlled Trial.
    Bastiaens GJH; van Meer MPA; Scholzen A; Obiero JM; Vatanshenassan M; van Grinsven T; Sim BKL; Billingsley PF; James ER; Gunasekera A; Bijker EM; van Gemert GJ; van de Vegte-Bolmer M; Graumans W; Hermsen CC; de Mast Q; van der Ven AJAM; Hoffman SL; Sauerwein RW
    Am J Trop Med Hyg; 2016 Mar; 94(3):663-673. PubMed ID: 26711509
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya.
    Hodgson SH; Juma E; Salim A; Magiri C; Njenga D; Molyneux S; Njuguna P; Awuondo K; Lowe B; Billingsley PF; Cole AO; Ogwang C; Osier F; Chilengi R; Hoffman SL; Draper SJ; Ogutu B; Marsh K
    Malar J; 2015 Apr; 14():182. PubMed ID: 25927522
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Plasmodium sporozoite survives RTS,S vaccination.
    Snounou G; Grüner AC; Müller-Graf CD; Mazier D; Rénia L
    Trends Parasitol; 2005 Oct; 21(10):456-61. PubMed ID: 16109504
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot study.
    Stanisic DI; Fink J; Mayer J; Coghill S; Gore L; Liu XQ; El-Deeb I; Rodriguez IB; Powell J; Willemsen NM; De SL; Ho MF; Hoffman SL; Gerrard J; Good MF
    BMC Med; 2018 Oct; 16(1):184. PubMed ID: 30293531
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres.
    Mordmüller B; Supan C; Sim KL; Gómez-Pérez GP; Ospina Salazar CL; Held J; Bolte S; Esen M; Tschan S; Joanny F; Lamsfus Calle C; Löhr SJ; Lalremruata A; Gunasekera A; James ER; Billingsley PF; Richman A; Chakravarty S; Legarda A; Muñoz J; Antonijoan RM; Ballester MR; Hoffman SL; Alonso PL; Kremsner PG
    Malar J; 2015 Mar; 14():117. PubMed ID: 25889522
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Effects of radiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine.
    Chattopadhyay R; Conteh S; Li M; James ER; Epstein JE; Hoffman SL
    Vaccine; 2009 Jun; 27(27):3675-80. PubMed ID: 19071177
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.
    Mensah VA; Gueye A; Ndiaye M; Edwards NJ; Wright D; Anagnostou NA; Syll M; Ndaw A; Abiola A; Bliss C; Gomis JF; Petersen I; Ogwang C; Dieye T; Viebig NK; Lawrie AM; Roberts R; Nicosia A; Faye B; Gaye O; Leroy O; Imoukhuede EB; Ewer KJ; Bejon P; Hill AV; Cisse B;
    PLoS One; 2016; 11(12):e0167951. PubMed ID: 27978537
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Malaria vaccine study site in Irian Jaya, Indonesia: Plasmodium falciparum incidence measurements and epidemiologic considerations in sample size estimation.
    Jones TR; Baird JK; Bangs MJ; Annis BA; Purnomo ; Basri H; Gunawan S; Harjosuwarno S; McElroy PD; Hoffman SL
    Am J Trop Med Hyg; 1994 Feb; 50(2):210-8. PubMed ID: 8116815
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Multidose Priming and Delayed Boosting Improve Plasmodium falciparum Sporozoite Vaccine Efficacy Against Heterologous P. falciparum Controlled Human Malaria Infection.
    Lyke KE; Singer A; Berry AA; Reyes S; Chakravarty S; James ER; Billingsley PF; Gunasekera A; Manoj A; Murshedkar T; Laurens MB; Church WP; Garver Baldwin LS; Sedegah M; Banania G; Ganeshan H; Guzman I; Reyes A; Wong M; Belmonte A; Ozemoya A; Belmonte M; Huang J; Villasante E; Sim BKL; Hoffman SL; Richie TL; Epstein JE;
    Clin Infect Dis; 2021 Oct; 73(7):e2424-e2435. PubMed ID: 32920641
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of SPf66 malaria vaccine efficacy in Brazil.
    Urdaneta M; Prata A; Struchiner CJ; Tosta CE; Tauil P; Boulos M
    Am J Trop Med Hyg; 1998 Mar; 58(3):378-85. PubMed ID: 9546423
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Analysis of serological data to investigate heterogeneity of malaria transmission: a community-based cross-sectional study in an area conducting elimination in Indonesia.
    Surendra H; Wijayanti MA; Murhandarwati EH; Irnawati ; Yuniarti T; Mardiati ; Herdiana ; Sumiwi ME; Hawley WA; Lobo NF; Cook J; Drakeley C; Supargiyono
    Malar J; 2019 Jul; 18(1):227. PubMed ID: 31286973
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Novel approaches to whole sporozoite vaccination against malaria.
    Bijker EM; Borrmann S; Kappe SH; Mordmüller B; Sack BK; Khan SM
    Vaccine; 2015 Dec; 33(52):7462-8. PubMed ID: 26469716
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Safety and Immunogenicity of Radiation-Attenuated PfSPZ Vaccine in Equatoguinean Infants, Children, and Adults.
    Jongo SA; Urbano Nsue Ndong Nchama V; Church LWP; Olotu A; Manock SR; Schindler T; Mtoro A; Kc N; Devinsky O; Zan E; Hamad A; Nyakarungu E; Mpina M; Deal A; Bijeri JR; Ondo Mangue ME; Ntutumu Pasialo BE; Nguema GN; Rivas MR; Chemba M; Ramadhani KK; James ER; Stabler TC; Abebe Y; Riyahi P; Saverino ES; Sax J; Hosch S; Tumbo A; Gondwe L; Segura JL; Falla CC; Phiri WP; Hergott DEB; García GA; Maas C; Murshedkar T; Billingsley PF; Tanner M; Ayekaba MO; Sim BKL; Daubenberger C; Richie TL; Abdulla S; Hoffman SL
    Am J Trop Med Hyg; 2023 Jul; 109(1):138-146. PubMed ID: 37160281
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
    Miura K; Keister DB; Muratova OV; Sattabongkot J; Long CA; Saul A
    Malar J; 2007 Aug; 6():107. PubMed ID: 17686163
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The March Toward Malaria Vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S319-33. PubMed ID: 26590432
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Novel sporozoite-based ELISpot assay to assess frequency of parasite-specific B cells after vaccination with irradiated sporozoites.
    Atre T; Robinson TM; Savransky T; Dutta S; Epstein JE; Bergmann-Leitner ES
    Malar J; 2019 May; 18(1):186. PubMed ID: 31142328
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genetic diversity of Merozoite surface protein 1-42 (MSP1-42) fragment of Plasmodium vivax from Indonesian isolates: Rationale implementation of candidate MSP1 vaccine.
    Murhandarwati EEH; Herningtyas EH; Puspawati P; Mau F; Chen SB; Shen HM; Chen JH
    Infect Genet Evol; 2020 Nov; 85():104573. PubMed ID: 32987191
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy.
    Bennett JW; Yadava A; Tosh D; Sattabongkot J; Komisar J; Ware LA; McCarthy WF; Cowden JJ; Regules J; Spring MD; Paolino K; Hartzell JD; Cummings JF; Richie TL; Lumsden J; Kamau E; Murphy J; Lee C; Parekh F; Birkett A; Cohen J; Ballou WR; Polhemus ME; Vanloubbeeck YF; Vekemans J; Ockenhouse CF
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004423. PubMed ID: 26919472
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Feasibility of direct venous inoculation of the radiation-attenuated Plasmodium falciparum whole sporozoite vaccine in children and infants in Siaya, western Kenya.
    Oneko M; Cherop YR; Sang T; Gutman JR; Wiegand R; Nyang'au EM; Odila AD; Akach D; Hamel MJ; Samuels AM; Kariuki S; Abebe Y; Nzuu EL; Wijayalath W; James ER; Sim BKL; Billingsley PF; Richie TL; Hoffman SL; Seder RA; Steinhardt LC
    Vaccine; 2020 Jun; 38(29):4592-4600. PubMed ID: 32444192
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Malaria vaccine clinical trials: what's on the horizon.
    Moreno A; Joyner C
    Curr Opin Immunol; 2015 Aug; 35():98-106. PubMed ID: 26172291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.